Results 151 to 160 of about 4,800,081 (359)

Comparative 10-year atherosclerotic cardiovascular disease risk in Ethiopian HIV patients on first-line versus second-line combined antiretroviral therapy

Atherosclerosis Plus
Background: Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of morbidity and mortality in HIV patients, but the impact of combined antiretroviral therapy regimens on its risk in Ethiopia is unclear. This study assessed the 10-year ASCVD
Balew Arega, Gashaw Solela, Tariku Fekadu, Tirhas Tadesse, Bekele Alemayehu, Amanuel Zeleke, Kidat Ayele   +6 more
doaj   +1 more source

Intensifying Antiretroviral Therapy With Raltegravir and Maraviroc During Early Human Immunodeficiency Virus (HIV) Infection Does Not Accelerate HIV Reservoir Reduction [PDF]

, 2015
Mario Ostrowski, Erika Benko, Feng Yun Yue, Connie J. Kim, Sanja Huibner, Terry Lee, Joel Singer, Jim Pankovich, Oliver Laeyendecker, Rupert Kaul, Gabor Kandel, Colin Kovacs   +11 more
openalex   +1 more source

Perceived disabling physical pain and suicidal ideation in aging people living with HIV cured of hepatitis C: A multi‐center survey in France (ANRS CO13 HEPAVIH)

HIV Medicine, EarlyView.
Abstract Introduction Suicidal ideation (SI) is highly prevalent among people living with HIV (PWH) and those with chronic hepatitis C virus (HCV) infection. Individuals with long‐term HIV–HCV co‐infection face specific health challenges, including heightened physical pain.
Tangui Barré, Clémence Ramier, Camelia Protopopescu, Philippe Sogni, Karine Ory, Tounes Saidi, Sophie Abgrall, Sylvie Brégigeon‐Ronot, Patrizia Carrieri, Fabienne Marcellin, the ANRS CO13 HEPAVIH Study Group, D. Salmon, L. Wittkop, P. Sogni, P. Carrieri, B. Spire, K. Ory, P. Trimoulet, J. Izopet, L. Serfaty, L. Alric, M. A. Valantin, G. Pialoux, J. Chas, K. Barange, A. Naqvi, E. Rosenthal, A. Bicart‐See, O. Bouchaud, A. Gervais, C. Lascoux‐Combe, C. Goujard, K. Lacombe, C. Duvivier, D. Neau, P. Morlat, F. Bani‐Sadr, F. Boufassa, C. Solas, H. Fontaine, L. Piroth, A. Simon, D. Zucman, F. Boué, P. Miailhes, E. Billaud, H. Aumaître, D. Rey, G. Peytavin, O. Zaeglel‐Faucher, D. Salmon, R. Usubillaga, P. Sogni, B. Bienvenu, O. Launay‐Puybasset, C. Bernasconi, A. Brunet, B. Silbermann, H. Boucher, F. Rollot, O. Zak Dit Zbar, S. Pol, C. Le Jeunne‐Ballif, P. Louergue, H. Mehawej, L. Merine‐Belardi, F. Almasi, N. Benammar, L. Alagna, S. Chaussade, L. Guillevin, B. Terris, C. Norgeux, C. Katlama, M. A. Valantin, H. Stitou, F. Caby, L. Paris, L. Schneider, R. Tubiana, A. Simon, L. Roudière, O. Benveniste, G. Breton, M. Bonmarchand, M. Kirstetter, F. Charlotte, F. Capron, V. Calvez, V. Thibaut, C. Soulie, B. Abdi, S. Lambert‐Niclot, S. Bregigeon‐Ronot, O. Zaegel‐Faucher, H. Laroche, A. Menard, E. Gaubert‐Marechal, S. Thirée, C. Tamalet, C. Hakimi, J. C. Poluzzi, C. Solas, G. Pialoux, J. Chas, L. Lassel, T. Lyavanc, S. Le Nagat, L. Slama, A. Canesti, P. Callard, B. Bachour, L. Alric, N. Sigur, D. Bonnet, M. Guivarch, K. Barange, J. M. Peron, P. Massip, L. Cuzin, M. Obada, E. Bonnet, M. Alvarez, E. Labau, M. Mularczyk, N. Bourdoncle, J. Penecy, L. Porte, F. Busato, S. Khatibi, J. Bernard, J. Selves, F. Larroquette, V. Ferrer, J. Chiabrandon, E. Rosenthal, C. Pradier, V. Mondain, P. Dellamonica, P. M. Roger, S. Ferrando, C. Ceppi, A. Naqvi, V. Rio, B. Dunais, B. Prouvost, F. De Salvadore‐Guillouet, I. Prebost, J. Durant, P. Pugliese, J. F. Michels, M. C. Saint‐Paul, C. Partouche, K. Nerini, O. Bouchaud, S. Abgrall, I. Zamord, F. Bidegain, M. Azghay, C. Rouyer, M. Tatay, F. Mechai, A. Martin, Y. Baazia, V. Iwaka‐Bande, A. Gerber, A. Bicart‐See, D. Garipuy, M. J. Ferro‐Collados, F. Gaches, F. Abravanel, F. Larroquette, J. Chiabrandon, A. Gervais, Y. Yazdanpanah, D. Henin, M. Bertine, M. Onambele, G. Peytavin, C. Lascoux‐Combe, T. Kandel, C. Pintado, J. M. Molina, C. Gatey, S. Gallien, W. Rozenbaum, M. Lafaurie, A. L. Munier, D. Ponscarme, M. Previllon, N. Colin De Verdière, M. G. Tateo, P. Palmer, A. Gabassi, R. Amarsy, M. C. Mazeron, K. Lacombe, J. Krause, D. Wendum, D. Fofana, C. Goujard, Y. Quertainmont, E. Teicher, L. Escaut, O. Derradji, C. Pallier, F. Veillet, L. Mouna, O. Lortholary, C. Duvivier, C. Rouzaud, M. Shoai Tehrani, S. Boucly, G. Obenga, J. P. Viard, E. Gardiennet, A. Mélard, D. Neau, A. Ochoa, E. Blanchard, C. Cazanave, M. Dupon, H. Dutronc, F. Dauchy, H. Wille, P. Bioulac‐Sage, P. Trimoulet, P. Morlat, D. Lacoste, F. Bonnet, N. Bernard, M. Hessamfar, F. Paccalin, C. Martell, M. C. Pertusa, M. Vandenhende, P. Mercié, T. Pistone, M. C. Receveur, M. Méchain, P. Duffau, C. Rivoisy, I. Faure, D. Malvy, J. Roger‐Schmeltz, D. Dondia, P. Bioulac‐Sage, P. Trimoulet, J. L. Pellegrin, E. Lazzaro, P. Bioulac‐Sage, P. Trimoulet, D. Zucman, C. Majerholc, J. E. Kahn, S. Hilaire, M. Brollo, F. Boué, S. Abgrall, J. Polo Devoto, I. Kansau, V. Chambrin, C. Pignon, C. Gatey, M. Favier, C. Deback, C. Vauloup, C. Pailler, F. Veillet, L. Mouna, J. L. Lopez Zaragoza, Y. Lévy, J. D. Lelièvre, A. S. Lascaux, S. Scerra, M. Bouvier‐Alias, E. Billaud, F. Raffi, C. Allavena, V. Reliquet, D. Boutoille, C. Biron, M. Lefebvre, N. Hall, S. Bouchez, C. Bernaud, O. Mounoury, A. Rodallec, L. Le Guen, P. Miailhes, D. Peyramond, C. Chidiac, F. Ader, F. Biron, A. Boibieux, L. Cotte, T. Ferry, T. Perpoint, M. Amiri, F. Valour, J. Koffi, F. Zoulim, F. Bailly, P. Lack, M. Maynard, S. Radenne, C. Augustin‐Normand, E. Vassel, T. T. Le‐Thi, L. Piroth, P. Chavanet, M. Duong Van Huyen, M. Buisson, A. Waldner‐Combernoux, S. Mahy, A. Fillion, H. Aumaître, M. Jean, A. Eden, M. Medus, M. Saada, S. Gaba, F. Bani‐Sadr, D. Lambert, Y. Nguyen, J. L. Berger, C. Rouger, V. Brodard, D Rey, M. Partasani, C. Cheneau, M. Priester, C. Bernard‐Henry, E. de Mautort, A. Ertle, F. Jegou, A. Fush, P. Gantner, S. Fafi‐Kremer, L. Pinheiro, F. Roustand, I. Kmiec, L. Traore, S. Le Puil, M. G. Tateo, S. Benothame, C. Pomes, C. Louisin, M. Mole, A. Adda, P. Thibaut, S. Poirier, R. Ben Rayana, M. P. Pietri, V. Le Baut, Y. Cuvillier, M. Alabatanah, F. Barret, F. Juster, C. Chesnel, D. Beniken, M. Sebire‐Le Cam, R. Monard, F. Badji, S. Caldato, T. Rojas Rojas, A. S. Ritleng, A. Ivanova, L. Chalal, Z. Julia, M. Cavellec, C. Chevalier, E. Paredes‐Manyari, S. Breau, N. Boughdiri, P. Fischer, C. Charles, S. Ogoudjobi, C. Brochier, V. Thoirain‐Galvan, L. Traore, S. Chaussee, S. Benothmane, A. Sondro, O. Camou, V. Godard, M. Kai, C. Gilbert, M. Pailler, L. Merchadou, L. Esterle, K. Ory, S. Gillet‐Rousseau, C. Khan, L. Abbad, M. Chalouni, V. Conte, F. Marcellin, R. Knight, M. Mora, C. Protopopescu, P. Roux, T. Barré   +402 more
wiley   +1 more source

Impact on weight of a Doravirine switch in people living with HIV

HIV Medicine, EarlyView.
Abstract Background and Objective Doravirine is among the first‐line recommended treatments for people living with HIV (PLHIV) in the 2025 EACS guidelines. As opposed to tenofovir alafenamide or anti‐integrase, its use was not associated with weight gain in clinical trials, but limited data are currently available in real life. In this cohort study, we
Nina Garofoli, Philippe Flandre, Jean‐Paul Vincensini, Quentin Richier, Priscille Couture, Karine Lacombe, Gilles Pialoux, Jean‐Luc Meynard   +7 more
wiley   +1 more source

Predictors of discontinuing injectable cabotegravir/rilpivirine and virologic outcomes after resuming oral antiretroviral therapy

HIV Medicine, EarlyView.
Abstract Objective Evaluate factors associated with discontinuation of long‐acting injectable (LAI) cabotegravir/rilpivirine (CAB/RPV) and describe virologic outcomes in those that returned to oral antiretroviral therapy (ART). Methods This is a retrospective cohort study at a single‐centre primary care HIV clinic.
Tali Faggiano, Jeffrey Yin, Nimish Patel, Afsana Karim, Kari Abulhosn, Laura Bamford, Lucas Hill   +6 more
wiley   +1 more source

Predictors of Poor Retention in Care of HIV-infected Patients Receiving Antiretroviral Therapy in Korea: Five-Year Hospital-based Retrospective Cohort Study [PDF]

, 2016
Shinwon Lee, Sun Hee Lee, Su Jin Lee, Kye‐Hyung Kim, Jeong Eun Lee, Heerim Cho, Seung‐Geun Lee, Dong Hwan Chen, Joo Seop Chung, Ihm Soo Kwak   +9 more
openalex   +1 more source

Polypharmacy in HIV: Rethinking what counts and why it matters

HIV Medicine, EarlyView.
Abstract Polypharmacy, the concurrent use of multiple medications, presents a growing challenge in HIV care as people living with HIV age and experience earlier onset of age‐related co‐morbidities. However, how polypharmacy is defined and assessed in HIV research remains inconsistent.
Luxsena Sukumaran, Alan Winston, Catia Marzolini, Saye Khoo, Marta Boffito, Nadia Naous, Caroline A. Sabin   +6 more
wiley   +1 more source

Prevention of HIV-1 infection with early antiretroviral therapy

Journal of family planning and reproductive health care, 2011
Michael Rayment
semanticscholar   +1 more source

Cervical intraepithelial neoplasia progression and regression among women living with HIV in Zambia

HIV Medicine, EarlyView.
Abstract Objectives Cervical screening and precancer treatment are less effective in women living with HIV (WLWH) than in women without HIV. We assessed high‐risk human papillomavirus (HR‐HPV) infection and cervical disease progression among screened WLWH in Zambia. Methods Participants underwent visual inspection with acetic acid (VIA), HR‐HPV testing
John Andoh, Katayoun Taghavi, Misinzo Moono, Partha Basu, Thamsanqa Madliwa, Mulindi H. Mwanahamuntu, Nicola Low, Albert Manasyan, Eliane Rohner   +8 more
wiley   +1 more source

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

New England Journal of Medicine, 2015
J. Lundgren, A. Babiker, F. Gordin, S. Emery, B. Grund, Shweta Sharma, A. Avihingsanon, D. Cooper, G. Fätkenheuer, J. Llibre, J. Molina, P. Munderi, M. Schechter, R. Wood, K. Klingman, S. Collins, H. Lane, A. Phillips, J. Neaton   +18 more
semanticscholar   +1 more source